GSK: Statement - Zantac (Ranitidine) Litigation - Russell and Hughes Cases
September 19, 2024
September 19, 2024
LONDON, England, Sept. 19 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Sept. 18, 2024:
GSK plc (LSE/NYSE: GSK) today confirmed it has reached two confidential settlements in cases filed in California State Court with Mr. John Russell, resolving his bladder cancer case, and with Ms. Annette Hughes, resolving her colorectal case. GSK does not admit any liability in either settlement. The cases will now be dismissed as to GSK.
GSK plc (LSE/NYSE: GSK) today confirmed it has reached two confidential settlements in cases filed in California State Court with Mr. John Russell, resolving his bladder cancer case, and with Ms. Annette Hughes, resolving her colorectal case. GSK does not admit any liability in either settlement. The cases will now be dismissed as to GSK.